IMMUNOTECH BIOPHARM LTDIMMUNOTECH BIOPHARM LTDIMMUNOTECH BIOPHARM LTD

IMMUNOTECH BIOPHARM LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.24 B‬HKD
−0.65HKD
‪−369.97 M‬HKD
0.00HKD
‪187.63 M‬
Beta (1Y)
0.25
Employees (FY)
210
Change (1Y)
−36 −14.63%
Revenue / Employee (1Y)
0.00HKD
Net income / Employee (1Y)
‪−1.76 M‬HKD

About IMMUNOTECH BIOPHARM LTD


CEO
Yu Wang
Headquarters
Beijing
Founded
2018
FIGI
BBG00VNXQ9M1
Immunotech Biopharm Ltd. is an investment holding company, which through its subsidiaries engages in research and development, manufacturing and commercialization of immune cell products for treatments of cancers in the PRC. The company was founded on April 11, 2018 and is headquartered in Beijing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6978 is 2.30 HKD — it has increased by 2.56% in the past 24 hours. Watch IMMUNOTECH BIOPHARM LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange IMMUNOTECH BIOPHARM LTD stocks are traded under the ticker 6978.
6978 stock has risen by 10.09% compared to the previous week, the month change is a 23.08% rise, over the last year IMMUNOTECH BIOPHARM LTD has showed a −47.37% decrease.
6978 reached its all-time high on Jun 4, 2021 with the price of 22.45 HKD, and its all-time low was 1.50 HKD and was reached on Nov 13, 2024. View more price dynamics on 6978 chart.
See other stocks reaching their highest and lowest prices.
6978 stock is 9.09% volatile and has beta coefficient of 0.25. Track IMMUNOTECH BIOPHARM LTD stock price on the chart and check out the list of the most volatile stocks — is IMMUNOTECH BIOPHARM LTD there?
Today IMMUNOTECH BIOPHARM LTD has the market capitalization of ‪1.24 B‬, it has increased by 5.26% over the last week.
Yes, you can track IMMUNOTECH BIOPHARM LTD financials in yearly and quarterly reports right on TradingView.
IMMUNOTECH BIOPHARM LTD is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
6978 net income for the last half-year is ‪−100.25 M‬ HKD, while the previous report showed ‪−234.11 M‬ HKD of net income which accounts for 57.18% change. Track more IMMUNOTECH BIOPHARM LTD financial stats to get the full picture.
No, 6978 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 210.00 employees. See our rating of the largest employees — is IMMUNOTECH BIOPHARM LTD on this list?
Like other stocks, 6978 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUNOTECH BIOPHARM LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMUNOTECH BIOPHARM LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMUNOTECH BIOPHARM LTD stock shows the sell signal. See more of IMMUNOTECH BIOPHARM LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.